Kyle D. Holen
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies, Glioma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Clinical Characteristics and Outcomes From an Institutional Series of Acinar Cell Carcinoma of the Pancreas and Related Tumors(2002)298 cited
- → The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor(2007)288 cited
- → Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study(2010)267 cited
- → Carcinoid Tumors(2008)229 cited
- → MC044h, a phase II trial of sorafenib in patients (pts) with metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study(2007)175 cited
- → Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α5β1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study(2008)157 cited
- → Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study(2017)132 cited
- → Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies(2009)124 cited
- → Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma(2016)110 cited
- → Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study(2015)101 cited